AGO bestätigt Perjeta/Herceptin und Kadcyla als Standardtherapien.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 153
- Publication type:
- Article
Works matching IS 16613791 AND DT 2016 AND VI 11 AND IP 2
Results: 17
1
2
Chemotherapie ohne Haarverlust -- Wunsch oder Wirklichkeit?
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 153
- By:
- Publication type:
- Article
3
OSTEOLOGIE-Kongress 2016: Gute Wirksamkeit von Denosumab (Prolia®) auch bei sekundärer Osteoporose bei der Behandlung des Mammakarzinoms.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 153
- Publication type:
- Article
4
Halaven® (Eribulin) zeigt als einzige Monochemotherapie einen signifikanten Überlebensvorteil beim metastasierten Brustkrebs.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 153
- Publication type:
- Article
5
Pertuzumab und Trastuzumab Emtansin sind in den jeweiligen Therapielinien die effektivsten Substanzen und der Behandlungsstandard.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 153
- By:
- Publication type:
- Article
6
Etablierter Standard ab der zweiten Linie beim metastasierten Mammakarzinom.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 152
- Publication type:
- Article
7
Psychologische Beratung für krebskranke Frauen in türkischer Sprache.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 151
- Publication type:
- Article
8
Appropriate Clinical Strategies for Breast Cancer Coexisting with Acute Myeloid Leukemia in the Genomic-Molecular Era: A Case Report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
9
Investigating Respondents and Nonrespondents of a Postal Breast Cancer Questionnaire Survey Regarding Differences in Age, Medical Conditions, and Therapy.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 139, doi. 10.1159/000446015
- By:
- Publication type:
- Article
10
Anti-HER2 Therapy Beyond Second-Line for HER2-Positive Metastatic Breast Cancer: A Short Review and Recommendations for Several Clinical Scenarios from a Spanish Expert Panel.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 133, doi. 10.1159/000443601
- By:
- Publication type:
- Article
11
The Role of Blue Dye in Sentinel Node Detection for Breast Cancer: A Retrospective Study of 203 Patients.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 128, doi. 10.1159/000445368
- By:
- Publication type:
- Article
12
Differentiation between Phyllodes Tumors and Fibroadenomas Based on Mammographic Sonographic and MRI Features.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 123, doi. 10.1159/000444377
- By:
- Publication type:
- Article
13
Clinical Development of the E75 Vaccine in Breast Cancer.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 116, doi. 10.1159/000446097
- By:
- Publication type:
- Article
14
Checkpoint Inhibitors and Their Application in Breast Cancer.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 108, doi. 10.1159/000445335
- By:
- Publication type:
- Article
15
Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of Immunotherapy.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 102, doi. 10.1159/000446061
- By:
- Publication type:
- Article
16
Tumor-Infiltrating Lymphocytes: A Promising Biomarker in Breast Cancer.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 96, doi. 10.1159/000444357
- By:
- Publication type:
- Article
17
Immunological Mechanisms in Breast Cancer -- from Bench to Bedside.
- Published in:
- Breast Care, 2016, v. 11, n. 2, p. 93, doi. 10.1159/000446266
- By:
- Publication type:
- Article